Cargando…

The “Life-World” trip of type 2 diabetes patients with allopathic treatment options: a triangulated qualitative investigation

BACKGROUND: Patients with type 2 diabetes usually start treatment with oral hypoglycaemic medications once they have been diagnosed. They eventually require insulin injections. We looked into the experiences of such patients with allopathic treatment alternatives over the course of their journey. ME...

Descripción completa

Detalles Bibliográficos
Autores principales: Mekashaw Bayked, Ewunetie, Haile Kahissay, Mesfin, Demeke Workneh, Birhanu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9586625/
https://www.ncbi.nlm.nih.gov/pubmed/36254398
http://dx.doi.org/10.1080/07853890.2022.2122552
_version_ 1784813727349997568
author Mekashaw Bayked, Ewunetie
Haile Kahissay, Mesfin
Demeke Workneh, Birhanu
author_facet Mekashaw Bayked, Ewunetie
Haile Kahissay, Mesfin
Demeke Workneh, Birhanu
author_sort Mekashaw Bayked, Ewunetie
collection PubMed
description BACKGROUND: Patients with type 2 diabetes usually start treatment with oral hypoglycaemic medications once they have been diagnosed. They eventually require insulin injections. We looked into the experiences of such patients with allopathic treatment alternatives over the course of their journey. METHODS: The study was conducted using a qualitative inquiry (phenomenological approach triangulated with modified grounded theory) from July 2019 to January 2020. A total of 24 participants (11 men and 13 women) were recruited purposively and interviewed face-to-face until theoretical saturation was reached. QDA Miner Lite v2.0.9 was used to categorise the data. RESULTS: The majority of patients had no previous notions regarding their illness. They did not have an emotional reaction to being diagnosed. They were uncomfortable on oral hypoglycaemic agents because of uncontrolled blood glucose and gastrointestinal disturbances, which were thought to be the main causes for medication changes. Initial insulin treatment experiences included fear of injection pain, difficulty self-injecting, and a sense of last resort. Insulin’s effectiveness, ease of injection with a little needle, and lack of gastrointestinal discomfort were all key reasons in changing the patients’ minds about it. Patients have rigorously adhered to insulin since it was found to improve health and bring life. CONCLUSION: The “life-world” journey of patients with type 2 diabetes with allopathic treatment options was started to be informed of the “unknown” (diabetes), which leads to the “ugly life” (with oral agents), and bridge to and living with the “terrible” (insulin), which was later found to be effective and perceived as “life.”: KEY MESSAGES: Patients with type 2 diabetes believed that life with oral hypoglycaemic medications was “boring.”. The major reasons for switching to insulin were “uncontrolled blood sugar levels” and “gastrointestinal disturbances” brought on by oral medications. Insulin first terrified type 2 diabetes patients, but they eventually referred to it as “life.”.
format Online
Article
Text
id pubmed-9586625
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-95866252022-10-22 The “Life-World” trip of type 2 diabetes patients with allopathic treatment options: a triangulated qualitative investigation Mekashaw Bayked, Ewunetie Haile Kahissay, Mesfin Demeke Workneh, Birhanu Ann Med Endocrinology BACKGROUND: Patients with type 2 diabetes usually start treatment with oral hypoglycaemic medications once they have been diagnosed. They eventually require insulin injections. We looked into the experiences of such patients with allopathic treatment alternatives over the course of their journey. METHODS: The study was conducted using a qualitative inquiry (phenomenological approach triangulated with modified grounded theory) from July 2019 to January 2020. A total of 24 participants (11 men and 13 women) were recruited purposively and interviewed face-to-face until theoretical saturation was reached. QDA Miner Lite v2.0.9 was used to categorise the data. RESULTS: The majority of patients had no previous notions regarding their illness. They did not have an emotional reaction to being diagnosed. They were uncomfortable on oral hypoglycaemic agents because of uncontrolled blood glucose and gastrointestinal disturbances, which were thought to be the main causes for medication changes. Initial insulin treatment experiences included fear of injection pain, difficulty self-injecting, and a sense of last resort. Insulin’s effectiveness, ease of injection with a little needle, and lack of gastrointestinal discomfort were all key reasons in changing the patients’ minds about it. Patients have rigorously adhered to insulin since it was found to improve health and bring life. CONCLUSION: The “life-world” journey of patients with type 2 diabetes with allopathic treatment options was started to be informed of the “unknown” (diabetes), which leads to the “ugly life” (with oral agents), and bridge to and living with the “terrible” (insulin), which was later found to be effective and perceived as “life.”: KEY MESSAGES: Patients with type 2 diabetes believed that life with oral hypoglycaemic medications was “boring.”. The major reasons for switching to insulin were “uncontrolled blood sugar levels” and “gastrointestinal disturbances” brought on by oral medications. Insulin first terrified type 2 diabetes patients, but they eventually referred to it as “life.”. Taylor & Francis 2022-10-17 /pmc/articles/PMC9586625/ /pubmed/36254398 http://dx.doi.org/10.1080/07853890.2022.2122552 Text en © 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Endocrinology
Mekashaw Bayked, Ewunetie
Haile Kahissay, Mesfin
Demeke Workneh, Birhanu
The “Life-World” trip of type 2 diabetes patients with allopathic treatment options: a triangulated qualitative investigation
title The “Life-World” trip of type 2 diabetes patients with allopathic treatment options: a triangulated qualitative investigation
title_full The “Life-World” trip of type 2 diabetes patients with allopathic treatment options: a triangulated qualitative investigation
title_fullStr The “Life-World” trip of type 2 diabetes patients with allopathic treatment options: a triangulated qualitative investigation
title_full_unstemmed The “Life-World” trip of type 2 diabetes patients with allopathic treatment options: a triangulated qualitative investigation
title_short The “Life-World” trip of type 2 diabetes patients with allopathic treatment options: a triangulated qualitative investigation
title_sort “life-world” trip of type 2 diabetes patients with allopathic treatment options: a triangulated qualitative investigation
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9586625/
https://www.ncbi.nlm.nih.gov/pubmed/36254398
http://dx.doi.org/10.1080/07853890.2022.2122552
work_keys_str_mv AT mekashawbaykedewunetie thelifeworldtripoftype2diabetespatientswithallopathictreatmentoptionsatriangulatedqualitativeinvestigation
AT hailekahissaymesfin thelifeworldtripoftype2diabetespatientswithallopathictreatmentoptionsatriangulatedqualitativeinvestigation
AT demekeworknehbirhanu thelifeworldtripoftype2diabetespatientswithallopathictreatmentoptionsatriangulatedqualitativeinvestigation
AT mekashawbaykedewunetie lifeworldtripoftype2diabetespatientswithallopathictreatmentoptionsatriangulatedqualitativeinvestigation
AT hailekahissaymesfin lifeworldtripoftype2diabetespatientswithallopathictreatmentoptionsatriangulatedqualitativeinvestigation
AT demekeworknehbirhanu lifeworldtripoftype2diabetespatientswithallopathictreatmentoptionsatriangulatedqualitativeinvestigation